Business Context and Reporting Period
This Form 8-K filing by Bristol-Myers Squibb Company reports a corporate governance event. The report date is July 10, 2017, covering the notification of a director's retirement effective July 21, 2017.
Key Financial Metrics
This filing does not contain financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing discloses the following material change to the Board of Directors:
- Departure: Laurie H. Glimcher, M.D., notified the Company of her retirement from the Board of Directors.
- Effective Date: July 21, 2017.
- Board Size Adjustment: Effective July 21, 2017, the size of the Board will be set at ten directors.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is strictly limited to the announcement of the director's departure.
Investor Verification Checklist
- Confirm the effective date of Laurie H. Glimcher's retirement (July 21, 2017).
- Verify the new authorized size of the Board of Directors (ten directors).
- Check for subsequent filings regarding the appointment of a replacement director to fill the vacancy.